Colgate Q4/FY2021: organic sales +4.5% FY; GAAP EPS down 19% on impairment; launches $200-240M productivity plan

COLGATE PALMOLIVE CO

2021-FY EPS reported $2.55 revenue$17,421,000,000

Full year net sales $17.42B (+6.0% YoY); organic sales growth +4.5%.
GAAP diluted EPS $2.55 (-19% YoY) due to Filorga goodwill impairment; base business EPS $3.21 (+5%).
Q4 net sales +2.0%, organic +3.0%; oral care and pet nutrition accelerated.
Board approved 2022 Global Productivity Initiative; estimated pre-tax charges $200-240M (80% severance), substantially complete by Dec 2022.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.